Stock 688192 DIZAL (JIANGSU) PHARMACEUTICAL CO., LTD.
Add to a list
To use this feature you must be a member
Log inSign up

Consensus Dizal (Jiangsu) Pharmaceutical Co., Ltd.

Equities

688192

CNE1000055W8

End-of-day quote Shanghai S.E.
Other stock markets
 06:00:00 2024-04-25 pm EDT 		5-day change 1st Jan Change
44.39 CNY +3.26% Intraday chart for Dizal (Jiangsu) Pharmaceutical Co., Ltd. +25.40% -7.23%
Apr. 24 Dizal Pharmaceutical Co., Ltd. Announces Two Abstracts Featuring the Latest Data on Sunvozertinib in Non-Small Cell Lung Cancer CI
Apr. 07 U.S. Food and Drug Administration Grants Breakthrough Therapy Designation to Dizal's Sunvozertinib for the First-Line Treatment of Patients with Advanced Non-Small Cell Lung Cancer Harboring EGFR Exon 20 Insertion Mutations CI

Evolution of the average Target Price on Dizal (Jiangsu) Pharmaceutical Co., Ltd.

Price target over the last 5 years

History of analyst recommendation changes

4d1648ea560e205d37a0.E3IVvC_qi4uqP9gKNgBekAaqGWo54fHWhSmVf14EWho.QwB-zWmNu-afXL86fEMt5G_9b11otLPlqEPYNRU3Y3xLP3nea6HA88tgnQ~00b3944d7c3d71faf5c88babf68d4f73

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
3
Last Close Price
44.39 CNY
Average target price
52.16 CNY
Spread / Average Target
+17.49%
High Price Target
54 CNY
Spread / Highest target
+21.65%
Low Price Target
50.31 CNY
Spread / Lowest Target
+13.34%

Consensus detail

Consensus revision (last 18 months)

EPS Revisions

Estimates Revisions

Annual profits - Rate of surprise

Company calendar
  1. Stock Market
  2. Equities
  3. 688192 Stock
  4. Consensus Dizal (Jiangsu) Pharmaceutical Co., Ltd.